CHGG(CHGG)
CHGG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $202M | $174M |
| Low | $198M | $170M |
| High | $206M | $177M |
| EBITDA Avg | $-17M | $-14M |
| Low | $-17M | $-14M |
| High | $-16M | $-14M |
| EBIT Avg | $-42M | $-36M |
| Low | $-42M | $-36M |
| High | $-41M | $-35M |
| Net Income Avg | $-14M | $-11M |
| Low | $-14M | $-12M |
| High | $-14M | $-11M |
| EPS Avg | $-0.13 | $-0.11 |
| Low | $-0.13 | $-0.11 |
| High | $-0.13 | $-0.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $45M | $44M | $42M | $41M | $41M | $38M |
| Low | $44M | $43M | $40M | $40M | $40M | $37M |
| High | $47M | $46M | $43M | $42M | $42M | $40M |
| EBITDA Avg | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M |
| Low | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M |
| High | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M |
| EBIT Avg | $-9M | $-9M | $-9M | $-8M | $-8M | $-8M |
| Low | $-10M | $-9M | $-9M | $-9M | $-9M | $-8M |
| High | $-9M | $-9M | $-8M | $-8M | $-8M | $-8M |
| Net Income Avg | $-6M | $-6M | $10M | $-1M | $-2M | $-2M |
| Low | $-7M | $-7M | $10M | $-1M | $-2M | $-2M |
| High | $-6M | $-6M | $10M | $-1M | $-2M | $-2M |
| EPS Avg | $-0.06 | $-0.06 | $0.09 | $-0.01 | $-0.02 | $-0.02 |
| Low | $-0.06 | $-0.06 | $0.09 | $-0.01 | $-0.02 | $-0.02 |
| High | $-0.05 | $-0.05 | $0.09 | $-0.01 | $-0.02 | $-0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |